Notificação de entrada na fase nacional - PCT
#1.3
08/16/2022
RPI 2693
Application data
Number
112022009672Type
Filing
Publication
PCT
US2020061923 The application was filed at the INPI on 11/24/2020. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 08/16/2022. We update with every new RPI gazette, published weekly.
Applicants
AGENSYS, INC.
US
SEAGEN INC.
US
Inventors
A. M. (pessoa física)
US
E. G. (pessoa física)
US
J. D. (pessoa física)
US
L. R. (pessoa física)
US
IPC Classification
Priority claims
US
62/940,209 · 11/25/2019
US
62/944,890 · 12/06/2019
Abstract
TRATAMENTO DE CÂNCERES COM CONJUGADOS ANTICORPO-FÁRMACO (ADC) QUE SE LIGAM A PROTEÍNAS 191P4D12. A presente invenção refere-se a métodos para o tratamento de cânceres com conjugados anticorpo-fármaco (ADC) que ligam a proteínas 191P4D12.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
08/16/2022
RPI 2693
#1.1
05/31/2022
RPI 2682
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.